Latest Biomarkers Stories
SOUTH SAN FRANCISCO, Calif., April 22, 2015 /PRNewswire/ -- MiNDERA Corp., a leader in the development of non-invasive diagnostic tests for dermatology, announced today the initiation of a research
RDIS(TM) and iOmics(TM) integration arcs across nonclinical, clinical and genomic biomarkers for targeted therapeutic drug development and stratified patient selection FOSTER CITY,
-- 300 patient US pilot study shows MiCheck(TM) test has 85% specificity - compared to 40% for existing PSA technology SYDNEY, April 20, 2015 /PRNewswire/ -- A NEW
ORLANDO, Fla., April 16, 2015 /PRNewswire/ -- MEDITE Cancer Diagnostics, Inc.
LONDON, April 9, 2015 /PRNewswire/ -- This report on cancer diagnostics analyzes the current as well as future prospects of various facets of the market in detail.
LONDON, March 30, 2015 /PRNewswire/ -- REPORT HIGHLIGHTSThe in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014.
Study Using Caris Molecular Intelligence's Multiplatform Profiling Service Highlighted in Plenary Session at Society of Surgical Oncology Symposium IRVING, Texas, March 27, 2015 /PRNewswire/
BETHESDA, Md., March 26, 2015 /PRNewswire/ -- Precision for Medicine (www.precisionformedicine.com) today announced
Patented blood test to be used in clinical trials and as a companion diagnostic for Can-Fite's Drugs PETACH TIKVA, Israel, March 18, 2015 /PRNewswire/ --
LONDON, March 16, 2015 /PRNewswire/ -- Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease
- An armed gangster.